Improving access to new diabetes medications for better health outcomes.
Building Equity Improvement into Quality Improvement in the use of New Glucose-lowering Drugs (GLDs) through Individualized Drug Value Assessment in People with Diabetes
['FUNDING_R01'] · UNIVERSITY OF FLORIDA · NIH-10877824
This study is looking to improve diabetes care by figuring out which groups of people, especially those facing challenges, can benefit the most from new medications that lower blood sugar, so everyone can have better health, no matter their background.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF FLORIDA (nih funded) |
| Locations | 1 site (GAINESVILLE, UNITED STATES) |
| Trial ID | NIH-10877824 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the quality of diabetes care by identifying patient groups who would benefit most from new glucose-lowering drugs (GLDs). It aims to address disparities in access to these medications, particularly among socially disadvantaged individuals. By analyzing data and using electronic health records, the project seeks to develop targeted interventions that promote the use of these high-benefit drugs in populations at risk for cardiovascular and kidney diseases. The ultimate goal is to ensure that all patients, regardless of their socioeconomic status, can achieve optimal health outcomes.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with type 2 diabetes, particularly those from socially disadvantaged backgrounds who are at high risk for cardiovascular and kidney diseases.
Not a fit: Patients who do not have diabetes or those who are not at high risk for cardiovascular and kidney diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved access to effective diabetes treatments for disadvantaged populations, resulting in better health outcomes.
How similar studies have performed: Previous research has shown that targeted interventions can effectively improve care quality and equity for high-benefit user groups, indicating a promising approach for this project.
Where this research is happening
GAINESVILLE, UNITED STATES
- UNIVERSITY OF FLORIDA — GAINESVILLE, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GUO, JINGCHUAN — UNIVERSITY OF FLORIDA
- Study coordinator: GUO, JINGCHUAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Adult-Onset Diabetes Mellitus